Last reviewed · How we verify
NCT03290339: AMETHYST
Feasibility of Ambulatory Hysterectomy
trial testing hysterectomy in Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus in 30 participants. Status unknown.
6 September 2019
Quick facts
| Lead sponsor | University Hospital, Caen |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 6 September 2017 |
| Primary completion | 6 September 2019 |
| Estimated completion | 6 December 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- hysterectomy
Conditions studied
- Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus — all drugs for Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus →
Sponsor
University Hospital, Caen
Who can join
Adults 18 to 70, female only, with Surgery; Maternal, Uterus or Pelvic Organs, Affecting Fetus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hysterectomy is one of the most performed surgery in women. Public authorities wish that one-day surgery become a majority and hysterectomy could be part of it in the future. The aim of this study is to determine the feasibility of ambulatory hysterectomy. Patients and methods: Investigators will realize an observational descriptive survey based on questionnaires in two surgical gynecology units. Women under 70 years old, who undergo hysterectomy will be included.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03290339
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of hysterectomy
Trials testing the same drug.
- NCT05374720 — Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy · NA · unknown
- NCT04120649 — Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma · completed
- NCT06253832 — Conservative Management of Placenta Accreta Spectrum · NA · completed
- NCT05261165 — Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer · completed
Other University Hospital, Caen trials
Trials by the same sponsor.
- NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
- NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
- NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
- NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
- NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03290339 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
- Last refreshed: 11 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03290339.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing